HYBRID EVENT: You can participate in person at Valencia, Spain or Virtually from your home or work.
Speaker at Drug Delivery Events - Nizama Hodzic
Bosnian, Bosnia and Herzegowina
Title : Impact and challenges supply chain realibity in pharmaceutical process development

Abstract:

Drug delivery systems as a technological system formulate and store drug molecules into suitable forms of medications. Effective process development plays a key role in mitigating risk, accelerating time-to-market, and significantly reducing development costs for pharmaceutical companies. Selecting appropriate raw materials, designing efficient production methods, optimizing critical process parameters are very important in risk reduction. Early identification of impact and challenges in supply chain realibity prevents costly late-stage redesigns. Material constraints necessitating cost-effective sourcing strategies and supply chain reliability for specialized ingredients have huge impact when scaling from laboratory to commercial production. Successfully navigating these challenges requires sophisticated development approaches, careful regulatory planning, strategic material sourcing, and creative engineering solutions to ensure commercial viability. By systematically addressing challenges related to scale-up, optimization, quality control, and regulatory compliance, process development creates manufacturing methods that consistently deliver high-quality medications to patients. It is important to unsure that raw materials flow uninterrupted through integrated processing steps to create finished products. Firstly, we have to know what are the realistic demand management production planning and scheduling. Product portfolios becoming more complex while regulations are becoming more stringent which rises the costs of PSC. Identification of product portfolio, long approval times, batch-to-batch variability and shortages, long lead times for scale-up, capacity constraints, adaptability to short-term demand fluctuations, quality assurance tasks lead times and very-specific products and process. Lead times raw materials get exceed. Entry of new rival products and change in the local regulatory policy can result in demand float throughout the year. The raw materials have to be procured months before the production as they are shipped from oversea suppliers. A sudden drop in demand could cause the production plan to be postponed or cancelled. As a result, excessive raw materials pile up in the warehouse. Requirements of regulatory agencies to withdraw API?s from the market due to impurity and stop production. Recent changes in the operating environment mean that companies are revisiting the components of their supply chains and identifying ways of extracting additional benefits from them. In the new decade, supply chain management and analytics will be shaped by new technologies. By analyzing data from IT-enabled devices and sensors, it is possible to identify patterns and trends that can help to optimize supply chain operations. The adoption of technologies such as supply chain network design, forecasting, predictive analytics, artificial intelligence, technology, and digital platform dashboards would help companies improve their processes, reduce efforts and cycle time, and increase profits.

Biography:

Sp.M.Pharm,M.Mgt Nizama Hodzic is Experienced Director in Pharmaceutical Logistics with a robust 20- year history in the pharmaceutical industry. Specialized Master of Pharmacy and certified Master of Management in the USA, with a focus on production planning, supply chain, pharmaceutical technology, science, and business economics. Demonstrated success in large-scale production planning and warehouse management. Proficient in optimizing production planning to maximize profits and minimize costs. Possesses a valuable skill set conducive to achieving diverse goals. Expertise in team building, leadership, and quality control management. Demonstrated ability to coordinate stocks, production, and sales, forge partnerships, and collaborate effectively with teams to ensure timely and cost-effective project completion. From 2004. Miss Hodzic verified her diploma in European Union. Constantly participates in public training, coaching, and speaking in all World Business Institution. Several published studies in drug development such as “Effects of physical characteristics of active ingredient on Atorvastatin calcium tablets”; European Journal of Pharmaceutical Sciences.2011 September; 44(1):80- 81.

Watsapp